You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金達威(002626.SZ):子公司年產200噸透明質酸鈉改擴建項目取得環評批覆
格隆匯 11-16 15:51

格隆匯11月16日丨金達威(002626.SZ)公佈,公司全資子公司內蒙古金達威藥業有限公司(簡稱“金達威藥業”)於2021年11月16日收到呼和浩特市生態環境局下發的《關於內蒙古金達威藥業有限公司年產200噸透明質酸鈉改擴建項目環境影響報吿書的批覆》(呼環政批字[2021]190號)。

該批覆同意金達威藥業在呼和浩特市托克托工業園區金達威藥業廠區內,建設年產200噸透明質酸鈉改擴建項目,並且落實批覆中提出的各項環保要求,確保污染物達標排放,嚴格執行配套設施的環境保護設施與主體工程同時設計、同時施工、同時投產使用的環境保護“三同時制度”。項目總投資6,000萬元,本項目含利用現有300噸膽固醇項目的閒置生產車間改造為提煉車間,現有單層彩鋼倉庫改建成2個佔地面積為2600m2的三層倉庫,所需設備部分新增部分利舊。

此次環評批覆取得後,公司及金達威藥業將嚴格按照環評批覆和相關法律法規的要求進行項目建設管理,確保項目實施和環境保護的協調和可持續性發展,爭取項目早日建成投產。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account